News
Announcements and updates from Nanomedx.
1 August 2026
MRFF grant to take ApixaShield towards first-in-human trial
Nanomedx co-founder Dr Richard Tan will lead a $426,000 MRFF Early to Mid-Career Researchers grant advancing the ApixaShield valve coating toward a first-in-human trial
1 November 2025
TTRA Drugs and Devices awards Tranche A funding
Nanomedx secures $750,000 in TTRA funding to advance its peripheral artery disease therapy towards first-in-human trials